News World Despite the pause, AstraZeneca - Oxford vaccine could be by the end...

Despite the pause, AstraZeneca – Oxford vaccine could be by the end of the year or early 2021

The executive director of the pharmaceutical AstraZeneca, Pascal Soriot, said that the coronavirus vaccine could be by the end of this year or early next, despite the last phase of the trial having been paused as a result of an adverse effect that occurred in a volunteer.

“We could have a vaccine by the end of this year, early next year” depending on how fast the regulatory body is moving, Soriot said at a meeting organised by the Tortoise media group.

The director explained that it is common for there to be pauses in trials caused by “adverse events”, but that “the difference is that the whole world is watching us” when referring to other research.

The laboratory developing the experimental vaccine with Oxford University suspended phase three trials on Tuesday after one of the volunteers in the United Kingdom developed adverse effects.

Soriot did not confirm the symptoms that the person had, but according to British media he suffered from neurological problems associated with a rare spinal inflammatory disorder called transverse myelitis.

In that sense, the executive said that more tests were being done on the person who fell ill and that the data will be presented to an independent safety committee that will evaluate them and decide if the tests can be resumed.

“At AstraZeneca we put science, safety and the interests of society at the centre of our work. This temporary hiatus is living proof that we follow those principles, as a committee of independent experts evaluates a single event at one of our test sites”, stated a previous statement from the laboratory.

Soriot also stressed that the World Health Organisation (WHO) pointed to the vaccine as the most promising to combat the coronavirus and maintained that it is very common for a trial to be suspended, with the difference that this time the world was looking at the investigation.

This is the vaccine that Argentina will also develop – through the biotechnology company mAbxience, of the Insud Group – in conjunction with Mexico for distribution in Latin America.

(London Reuters)

Top Stories

UPDATE- Twenty-five new coronavirus cases today out of 2,950 tests total

According to an update the Ministry's Epidemiological Surveillance Unit has received it is announced that 10 additional new cases of the SARS-CoV-II virus were...

Bag snatcher caught red handed thanks to observant woman

A 22-year-old foreigner was arrested on Friday for snatching the bag of a 63-year-old foreign woman in a restaurant in Paphos. The theft was...

Fire in two adjacent houses in Fterikoudi under control (photos)

A fire broke out in two adjacent houses in Fterikoudi village in Nicosia a little before 2 pm on Saturday causing extensive damage. According to...

Man, 26, arrested for causing malicious damage to antennas

Police arrested a 26-year-old man on Saturday afternoon in connection with cases of attempted arson and causing malicious damage to antennas of mobile phone...

Fifteen new coronavirus cases detected out of 2,891 tests

The Ministry of Health has announced that 15 new cases of the SARS-CoV-II virus were detected in Cyprus over the past 24 hours out...

Taste

Swordfish with aubergines

To toast the sesame seeds: place sesame seeds in a small non-stick frying pan over low heat and stir until you begin to smell...

Chicken with okra and bulgur wheat

Heat the oil in a pan and sauté the okra until golden. Remove the okra, lay out in an oven tray and sprinkle with...

Ravioli

Just a little before serving, heat the broth and add the ravioli. (If the ravioli is frozen you don’t have to defrost). Heat them...

Seafood kebab with avocado salad

Place the mussels, shrimps and salmon in a bowl together with tarragon and lemon zest. Season and cover, keeping in the fridge for 15...